ConductScience.org, home

Comparison · NCT00906347-d8983577

Misoprostol Augmentation vs Oxytocin Augmentation: Uterine Tachysystole

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Misoprostol Augmentation vs Oxytocin Augmentation: Uterine Tachysystole. Trial comparisons, record NCT00906347-d8983577. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00906347-d8983577

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2840.2230.355wilson
Risk in group 20.2360.1790.304wilson
Risk difference, group 1 minus group 20.0485-0.04350.139newcombe hybrid score
Risk ratio, group 1 over group 21.210.8451.72log
Odds ratio, group 1 over group 21.290.7972.08log
Number needed to treat, for one more participant with the outcome on Misoprostol Augmentation than on Oxytocin Augmentation20.6from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Misoprostol AugmentationWomen with hypotonic labor and a clinical decision to proceed with labor augmentation will receive oral misoprostol.~Misoprostol : 75 micrograms orally every 4 hours for up to 2 doses.50176OG000
Group 2Oxytocin Augmentation
Women with hypotonic labor and a clinical decision to proceed with labor augmentation will receive intravenous oxytocin.~Oxytocin : Intravenous oxytocin will be administered per the established Labor and Delivery protocol at Parkland Memorial Hospital
41174OG001

Outcome

Type
PRIMARY
Title
Uterine Tachysystole
Description
Defined as six contractions in two consecutive 10-minute periods
Time frame
Up to four hours after administration of study drug
Population
Intent to treat

Source ClinicalTrials.gov

Trial

Title
A Trial of Oral Misoprostol for Labor Augmentation
NCT number
NCT00906347
Phases
PHASE4
Conditions
Labor Augmentation
Interventions
Misoprostol, Oxytocin
Lead sponsor
University of Texas Southwestern Medical Center
Results first posted
2012-11-07

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00906347-d8983577